Puma Biotechnology (PBYI) Change in Inventory (2017 - 2026)
Puma Biotechnology (PBYI) posted Change in Inventory of $3.2 million for Q1 2026, up 180.23% on a QoQ basis from -$4.0 million in Q4 2025, and up 11670.37% year-over-year from N/an in Q1 2025.
Puma Biotechnology (PBYI) Change in Inventory (2017 - 2026) Analysis & Trends
Puma Biotechnology's Change in Inventory history runs 10 years deep, the most recent figure standing at $3.2 million for Q1 2026.
- Quarterly Change in Inventory rose 11670.37% year-over-year to $3.2 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$58000.0 (down 103.51% YoY) and the FY2025 annual result came in at -$3.2 million, down 295.19% from the prior year.
- Change in Inventory was $3.2 million for Q1 2026 at Puma Biotechnology, up from -$4.0 million in the prior quarter.
- Across five years, Change in Inventory topped out at $6.1 million in Q4 2024 and bottomed at -$6.4 million in Q3 2024.
- A 5-year average of $93176.5 and a median of $20000.0 in 2024 frame the typical range for Change in Inventory.
- Annual changes were most pronounced in 2022 — Change in Inventory plunged 854.64% — and 2026, when it jumped 11670.37%.
- Puma Biotechnology's Change in Inventory stood at -$926000.0 in 2022, then soared by 251.3% to $1.4 million in 2023, then soared by 331.91% to $6.1 million in 2024, then slumped by 165.46% to -$4.0 million in 2025, then surged by 180.23% to $3.2 million in 2026.
- Business Quant data shows PBYI's Change in Inventory at $3.2 million in Q1 2026, -$4.0 million in Q4 2025, and $885000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Inventory (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 71.84 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 97.70 Mn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | -26.60 Mn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | - |
| 10 | Puma Biotechnology | 407.27 Mn | 368.99 Mn | 34.39 Mn | 3.18 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 3.18 Mn |
| Mar 31, 2026 | 3.18 Mn |
| Dec 31, 2025 | -3.96 Mn |
| Dec 31, 2025 | -3.96 Mn |
| Sep 30, 2025 | 885,000.00 |
| Sep 30, 2025 | 885,000.00 |
| Jun 30, 2025 | -160,000.00 |
| Jun 30, 2025 | -160,000.00 |
| Mar 31, 2025 | 27,000.00 |
| Mar 31, 2025 | 27,000.00 |
| Dec 31, 2024 | 6.05 Mn |
| Dec 31, 2024 | 6.05 Mn |
| Sep 30, 2024 | -6.38 Mn |
| Sep 30, 2024 | -6.38 Mn |
| Jun 30, 2024 | 1.95 Mn |
| Jun 30, 2024 | 1.95 Mn |
| Mar 31, 2024 | 20,000.00 |
| Mar 31, 2024 | 20,000.00 |
| Dec 31, 2023 | 1.40 Mn |
| Dec 31, 2023 | 1.40 Mn |